---
document_datetime: 2025-12-02 05:26:25
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/senstend.html
document_name: senstend.html
version: success
processing_time: 0.1062584
conversion_datetime: 2025-12-27 23:38:45.251602
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Senstend

[RSS](/en/individual-human-medicine.xml/67241)

##### Withdrawn

This medicine's authorisation has been withdrawn

lidocaine / prilocaine Medicine Human Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on Senstend](#news-on)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 24 June, the European Commission withdrew the marketing authorisation for Senstend (lidocaine / prilocaine) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, Plethora Pharma Solutions Limited, which notified the European Commission of its decision not to market the product in the EU for commercial reasons.

Senstend was granted marketing authorisation in the EU on 14 November 2019 for the treatment of primary premature ejaculation. The marketing authorisation was initially valid for a 5-year period. The product had not been marketed in the EU since its approval in 2019. Senstend was a duplicate application to Fortacin, which is marketed in several EU countries. The marketing authorisation holder will maintain the marketing authorisation for Fortacin.

The European Public Assessment Report (EPAR) for Senstend is updated to indicate that the marketing authorisation is no longer valid.

Senstend : EPAR - Medicine overview

Reference Number: EMA/519240/2019

English (EN) (670.21 KB - PDF)

**First published:** 29/11/2019

**Last updated:** 05/07/2022

[View](/en/documents/overview/senstend-epar-medicine-overview_en.pdf)

[Other languages (22)](#file-language-dropdown-194)

български (BG) (1.29 MB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/bg/documents/overview/senstend-epar-medicine-overview_bg.pdf)

español (ES) (1.22 MB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/es/documents/overview/senstend-epar-medicine-overview_es.pdf)

čeština (CS) (1.27 MB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/cs/documents/overview/senstend-epar-medicine-overview_cs.pdf)

dansk (DA) (1.22 MB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/da/documents/overview/senstend-epar-medicine-overview_da.pdf)

Deutsch (DE) (1.22 MB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/de/documents/overview/senstend-epar-medicine-overview_de.pdf)

eesti keel (ET) (1.21 MB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/et/documents/overview/senstend-epar-medicine-overview_et.pdf)

ελληνικά (EL) (1.28 MB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/el/documents/overview/senstend-epar-medicine-overview_el.pdf)

français (FR) (1.22 MB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/fr/documents/overview/senstend-epar-medicine-overview_fr.pdf)

hrvatski (HR) (1.24 MB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/hr/documents/overview/senstend-epar-medicine-overview_hr.pdf)

italiano (IT) (686.49 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/it/documents/overview/senstend-epar-medicine-overview_it.pdf)

latviešu valoda (LV) (752.95 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/lv/documents/overview/senstend-epar-medicine-overview_lv.pdf)

lietuvių kalba (LT) (711.1 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/lt/documents/overview/senstend-epar-medicine-overview_lt.pdf)

magyar (HU) (1.27 MB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/hu/documents/overview/senstend-epar-medicine-overview_hu.pdf)

Malti (MT) (747.25 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/mt/documents/overview/senstend-epar-medicine-overview_mt.pdf)

Nederlands (NL) (687.46 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/nl/documents/overview/senstend-epar-medicine-overview_nl.pdf)

polski (PL) (744.53 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/pl/documents/overview/senstend-epar-medicine-overview_pl.pdf)

português (PT) (688.19 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/pt/documents/overview/senstend-epar-medicine-overview_pt.pdf)

română (RO) (708.86 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/ro/documents/overview/senstend-epar-medicine-overview_ro.pdf)

slovenčina (SK) (743.36 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/sk/documents/overview/senstend-epar-medicine-overview_sk.pdf)

slovenščina (SL) (701.62 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/sl/documents/overview/senstend-epar-medicine-overview_sl.pdf)

Suomi (FI) (1.21 MB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/fi/documents/overview/senstend-epar-medicine-overview_fi.pdf)

svenska (SV) (666.47 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/sv/documents/overview/senstend-epar-medicine-overview_sv.pdf)

Senstend : EPAR - Risk-management-plan summary

English (EN) (1.21 MB - PDF)

**First published:** 29/11/2019

**Last updated:** 05/07/2022

[View](/en/documents/rmp-summary/senstend-epar-risk-management-plan-summary_en.pdf)

## Product information

Senstend : EPAR - Product information

English (EN) (938.11 KB - PDF)

**First published:** 29/11/2019

**Last updated:** 05/07/2022

[View](/en/documents/product-information/senstend-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-623)

български (BG) (1.64 MB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/bg/documents/product-information/senstend-epar-product-information_bg.pdf)

español (ES) (1.66 MB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/es/documents/product-information/senstend-epar-product-information_es.pdf)

čeština (CS) (1.37 MB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/cs/documents/product-information/senstend-epar-product-information_cs.pdf)

dansk (DA) (914.89 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/da/documents/product-information/senstend-epar-product-information_da.pdf)

Deutsch (DE) (1.01 MB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/de/documents/product-information/senstend-epar-product-information_de.pdf)

eesti keel (ET) (985.34 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/et/documents/product-information/senstend-epar-product-information_et.pdf)

ελληνικά (EL) (1.71 MB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/el/documents/product-information/senstend-epar-product-information_el.pdf)

français (FR) (926.09 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/fr/documents/product-information/senstend-epar-product-information_fr.pdf)

hrvatski (HR) (831.74 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/hr/documents/product-information/senstend-epar-product-information_hr.pdf)

íslenska (IS) (806.43 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/is/documents/product-information/senstend-epar-product-information_is.pdf)

italiano (IT) (917.55 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/it/documents/product-information/senstend-epar-product-information_it.pdf)

latviešu valoda (LV) (1.46 MB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/lv/documents/product-information/senstend-epar-product-information_lv.pdf)

lietuvių kalba (LT) (1.01 MB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/lt/documents/product-information/senstend-epar-product-information_lt.pdf)

magyar (HU) (882.02 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/hu/documents/product-information/senstend-epar-product-information_hu.pdf)

Malti (MT) (1.42 MB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/mt/documents/product-information/senstend-epar-product-information_mt.pdf)

Nederlands (NL) (917.64 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/nl/documents/product-information/senstend-epar-product-information_nl.pdf)

norsk (NO) (989.64 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/no/documents/product-information/senstend-epar-product-information_no.pdf)

polski (PL) (1.45 MB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/pl/documents/product-information/senstend-epar-product-information_pl.pdf)

português (PT) (993.24 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/pt/documents/product-information/senstend-epar-product-information_pt.pdf)

română (RO) (1.02 MB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/ro/documents/product-information/senstend-epar-product-information_ro.pdf)

slovenčina (SK) (1.43 MB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/sk/documents/product-information/senstend-epar-product-information_sk.pdf)

slovenščina (SL) (1.46 MB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/sl/documents/product-information/senstend-epar-product-information_sl.pdf)

Suomi (FI) (993.89 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/fi/documents/product-information/senstend-epar-product-information_fi.pdf)

svenska (SV) (919.07 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/sv/documents/product-information/senstend-epar-product-information_sv.pdf)

14/11/2019

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Senstend : EPAR - All authorised presentations

English (EN) (618.59 KB - PDF)

**First published:** 29/11/2019

**Last updated:** 05/07/2022

[View](/en/documents/all-authorised-presentations/senstend-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-559)

български (BG) (690.65 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/bg/documents/all-authorised-presentations/senstend-epar-all-authorised-presentations_bg.pdf)

español (ES) (619.32 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/es/documents/all-authorised-presentations/senstend-epar-all-authorised-presentations_es.pdf)

čeština (CS) (680 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/cs/documents/all-authorised-presentations/senstend-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (619.86 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/da/documents/all-authorised-presentations/senstend-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (620.79 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/de/documents/all-authorised-presentations/senstend-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (618 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/et/documents/all-authorised-presentations/senstend-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (687.72 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/el/documents/all-authorised-presentations/senstend-epar-all-authorised-presentations_el.pdf)

français (FR) (620.68 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/fr/documents/all-authorised-presentations/senstend-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (662.45 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/hr/documents/all-authorised-presentations/senstend-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (826.65 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/is/documents/all-authorised-presentations/senstend-epar-all-authorised-presentations_is.pdf)

italiano (IT) (619.23 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/it/documents/all-authorised-presentations/senstend-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (681.09 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/lv/documents/all-authorised-presentations/senstend-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (663.74 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/lt/documents/all-authorised-presentations/senstend-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (678.77 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/hu/documents/all-authorised-presentations/senstend-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (681.6 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/mt/documents/all-authorised-presentations/senstend-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (617.33 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/nl/documents/all-authorised-presentations/senstend-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (619.89 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/no/documents/all-authorised-presentations/senstend-epar-all-authorised-presentations_no.pdf)

polski (PL) (680.16 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/pl/documents/all-authorised-presentations/senstend-epar-all-authorised-presentations_pl.pdf)

português (PT) (619.33 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/pt/documents/all-authorised-presentations/senstend-epar-all-authorised-presentations_pt.pdf)

română (RO) (663.19 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/ro/documents/all-authorised-presentations/senstend-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (679.4 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/sk/documents/all-authorised-presentations/senstend-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (676.69 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/sl/documents/all-authorised-presentations/senstend-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (617.2 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/fi/documents/all-authorised-presentations/senstend-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (619.13 KB - PDF)

**First published:**

29/11/2019

**Last updated:**

05/07/2022

[View](/sv/documents/all-authorised-presentations/senstend-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Senstend Active substance

- lidocaine
- prilocaine

International non-proprietary name (INN) or common name

- lidocaine
- prilocaine

Therapeutic area (MeSH) Premature Ejaculation Anatomical therapeutic chemical (ATC) code N01BB20

### Pharmacotherapeutic group

Anesthetics

### Therapeutic indication

Senstend is indicated for the treatment of primary premature ejaculation in adult men.

## Authorisation details

EMA product number EMEA/H/C/005298 Marketing authorisation holder

Plethora Pharma Solutions Limited

32 Merrion Street

Opinion adopted 19/09/2019 Marketing authorisation issued 14/11/2019

## Assessment history

## Initial marketing authorisation documents

Senstend : EPAR - Public assessment report

Adopted

Reference Number: EMA/625405/2019

English (EN) (848.35 KB - PDF)

**First published:** 29/11/2019

**Last updated:** 05/07/2022

[View](/en/documents/assessment-report/senstend-epar-public-assessment-report_en.pdf)

CHMP summary of positive opinion for Senstend

Adopted

Reference Number: EMA/CHMP/382383/2019

English (EN) (637.36 KB - PDF)

**First published:** 20/09/2019

**Last updated:** 05/07/2022

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-senstend_en.pdf)

#### News on Senstend

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 16-19 September 2019](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-16-19-september-2019) 20/09/2019

**This page was last updated on** 05/07/2022

## Share this page

[Back to top](#main-content)